Medtronic (MDT +0.3%) says it's successfully completed the first phase of feasibility studies on...

|About: Medtronic plc (MDT)|By:, SA News Editor

Medtronic (MDT +0.3%) says it's successfully completed the first phase of feasibility studies on its next-generation renal denervation system, which features a simultaneously firing multi-electrode catheter and advanced radio-frequency generator. A total of nine patients were treated with a 100% acute success rate in accessing the vessels and delivering therapy. The system is only in its investigational phase however, and isn't yet commercially available anywhere in the world.